NWRN — Newron Pharmaceuticals SpA Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapNeutral

Annual balance sheet for Newron Pharmaceuticals SpA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	31.3	34.6	22.8	12.6	9.83
Net Total Accounts Receivable
Net Total Receivables	5.76	4.05	4.97	5.18	47.1
Prepaid Expenses
Total Current Assets	37.9	39.4	28.5	19.7	61.1
Net Property, Plant And Equipment	0.734	0.577	0.527	0.405	0.834
Net Intangible Assets
Long Term Notes Receivable
Total Assets	51.2	50.5	37.2	25.9	63.9
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	6.89	3.65	5.04	28.9	23.5
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	34	47.4	51.2	55.8	62.5
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	17.2	3.11	-14	-29.9	1.46
Total Liabilities & Shareholders' Equity	51.2	50.5	37.2	25.9	63.9
Total Common Shares Outstanding